<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<style type="text/css">
.txt { white-space:nowrap; }
#f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
#f1 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff8; src: url("8.ttf"); }
#f2 { font-family:ff8,monospace; font-weight:normal; font-style:normal; }
@font-face { font-family: ff5; src: url("5.ttf"); }
#f3 { font-family:ff5,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff1; src: url("1.ttf"); }
#f4 { font-family:ff1,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff2; src: url("2.ttf"); }
#f5 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff4; src: url("4.ttf"); }
#f6 { font-family:ff4,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url("0.ttf"); }
#f7 { font-family:ff0,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff3; src: url("3.ttf"); }
#f8 { font-family:ff3,sans-serif; font-weight:normal; font-style:normal; }
</style>
</head>
<body>
<img id="background" style="position:absolute; left:0px; top:0px;" width="595" height="841" src="page6.png">
<div class="txt" style="position:absolute; left:56px; top:138px;"><span id="f8" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">차후 임상 진척도에 따라</span></div>
<div class="txt" style="position:absolute; left:56px; top:154px;"><span id="f8" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">파이프라인 가치상승 기대</span></div>
<div class="txt" style="position:absolute; left:191px; top:110px;"><span id="f4" style="font-size:12px;vertical-align:baseline;color:rgba(85,146,206,1);">2. SK</span><span id="f5" style="font-size:12px;vertical-align:baseline;color:rgba(85,146,206,1);">바이오팜 가치 </span><span id="f4" style="font-size:12px;vertical-align:baseline;color:rgba(85,146,206,1);">4.9</span><span id="f5" style="font-size:12px;vertical-align:baseline;color:rgba(85,146,206,1);">조원으로 평가</span></div>
<div class="txt" style="position:absolute; left:191px; top:136px;"><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">우리는 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">SK</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">바이오팜의 파이프라인 가치를 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">4.9</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">조원으로 평가한다</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. </span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">솔리암페톨 가</span></div>
<div class="txt" style="position:absolute; left:191px; top:152px;"><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">치 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">4,520</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">억원</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">, </span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">세노바메이트 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">3.5</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">조원</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">, </span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">그 외 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">6</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">개의 파이프라인 합산 가치 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">9,470</span></div>
<div class="txt" style="position:absolute; left:191px; top:168px;"><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">억원을 합산하여 산출했다</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. </span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">임상이 완료된 솔리암페톨과 세노바메이트를 제외한</span></div>
<div class="txt" style="position:absolute; left:191px; top:184px;"><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">기타 파이프라인의 가치는 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">2024</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">년 예상 시장규모를 기반으로 현재 임상 진행 단</span></div>
<div class="txt" style="position:absolute; left:191px; top:200px;"><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">계 등을 고려하여 산출했다</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. </span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">차후 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">6</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">개 파이프라인의 임상이 진척을 나타낸다면</span></div>
<div class="txt" style="position:absolute; left:191px; top:216px;"><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">기업 가치의 추가적인 상승을 기대할 수 있을 것이다</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">.</span></div>
<div class="txt" style="position:absolute; left:191px; top:246px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">&lt;</span><span id="f8" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">표 </span><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">4&gt; </span><span id="f8" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">파이프라인 가치</span></div>
<div class="txt" style="position:absolute; left:191px; top:268px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">파이프라인</span></div>
<div class="txt" style="position:absolute; left:191px; top:283px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Solriamfetol</span></div>
<div class="txt" style="position:absolute; left:191px; top:294px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Cenobamate</span></div>
<div class="txt" style="position:absolute; left:191px; top:305px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Carisbamate</span></div>
<div class="txt" style="position:absolute; left:191px; top:317px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Relenopride</span></div>
<div class="txt" style="position:absolute; left:191px; top:328px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">SKL13865</span></div>
<div class="txt" style="position:absolute; left:191px; top:339px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">SKL20540</span></div>
<div class="txt" style="position:absolute; left:191px; top:351px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">YKP10461</span></div>
<div class="txt" style="position:absolute; left:191px; top:362px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">SKL-PSY/FZ-016</span></div>
<div class="txt" style="position:absolute; left:191px; top:374px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">합산가치</span></div>
<div class="txt" style="position:absolute; left:191px; top:388px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">자료</span><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">: SK, </span><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">한국투자증권</span></div>
<div class="txt" style="position:absolute; left:290px; top:268px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">가치</span><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(</span><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">십억원</span><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">)</span></div>
<div class="txt" style="position:absolute; left:317px; top:283px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">452</span></div>
<div class="txt" style="position:absolute; left:310px; top:294px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">3,453</span></div>
<div class="txt" style="position:absolute; left:317px; top:305px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">311</span></div>
<div class="txt" style="position:absolute; left:321px; top:317px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">57</span></div>
<div class="txt" style="position:absolute; left:317px; top:328px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">121</span></div>
<div class="txt" style="position:absolute; left:317px; top:339px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">293</span></div>
<div class="txt" style="position:absolute; left:317px; top:351px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">166</span></div>
<div class="txt" style="position:absolute; left:323px; top:362px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">-</span></div>
<div class="txt" style="position:absolute; left:310px; top:374px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">4,853</span></div>
<div class="txt" style="position:absolute; left:378px; top:268px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">적응증</span></div>
<div class="txt" style="position:absolute; left:372px; top:283px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">수면장애</span></div>
<div class="txt" style="position:absolute; left:378px; top:294px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">뇌전증</span></div>
<div class="txt" style="position:absolute; left:362px; top:305px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">희귀 뇌전증</span></div>
<div class="txt" style="position:absolute; left:346px; top:317px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">과민성대장증후군</span></div>
<div class="txt" style="position:absolute; left:362px; top:328px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">집중력 장애</span></div>
<div class="txt" style="position:absolute; left:347px; top:339px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">조현병</span><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">, </span><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">인지장애</span></div>
<div class="txt" style="position:absolute; left:372px; top:351px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">파킨슨병</span></div>
<div class="txt" style="position:absolute; left:378px; top:362px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">조울증</span></div>
<div class="txt" style="position:absolute; left:415px; top:263px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2024 </span><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">년 시장크기</span></div>
<div class="txt" style="position:absolute; left:436px; top:272px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(</span><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">백만달러</span><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">)</span></div>
<div class="txt" style="position:absolute; left:449px; top:283px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">1,617</span></div>
<div class="txt" style="position:absolute; left:449px; top:294px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">6,325</span></div>
<div class="txt" style="position:absolute; left:449px; top:305px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">1,122</span></div>
<div class="txt" style="position:absolute; left:449px; top:317px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">1,161</span></div>
<div class="txt" style="position:absolute; left:449px; top:328px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">4,427</span></div>
<div class="txt" style="position:absolute; left:446px; top:339px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">10,715</span></div>
<div class="txt" style="position:absolute; left:449px; top:351px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">6,088</span></div>
<div class="txt" style="position:absolute; left:456px; top:362px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">429</span></div>
<div class="txt" style="position:absolute; left:511px; top:268px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">임상단계</span></div>
<div class="txt" style="position:absolute; left:524px; top:283px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">완료</span></div>
<div class="txt" style="position:absolute; left:524px; top:294px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">완료</span></div>
<div class="txt" style="position:absolute; left:525px; top:305px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2</span><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">상</span></div>
<div class="txt" style="position:absolute; left:525px; top:317px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2</span><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">상</span></div>
<div class="txt" style="position:absolute; left:525px; top:328px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">1</span><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">상</span></div>
<div class="txt" style="position:absolute; left:525px; top:339px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">1</span><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">상</span></div>
<div class="txt" style="position:absolute; left:525px; top:351px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">1</span><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">상</span></div>
<div class="txt" style="position:absolute; left:517px; top:362px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">전임상</span></div>
<div class="txt" style="position:absolute; left:56px; top:457px;"><span id="f8" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">현지시간 </span><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">3</span><span id="f8" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">월 </span><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">21</span><span id="f8" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">일</span></div>
<div class="txt" style="position:absolute; left:56px; top:473px;"><span id="f8" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">판매허가 결정</span></div>
<div class="txt" style="position:absolute; left:56px; top:617px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">Narcolepsy</span><span id="f8" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">나 </span><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">OSA</span><span id="f8" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">에서</span></div>
<div class="txt" style="position:absolute; left:56px; top:633px;"><span id="f8" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">오는 </span><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">EDS </span><span id="f8" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">치료제</span></div>
<div class="txt" style="position:absolute; left:191px; top:429px;"><span id="f4" style="font-size:12px;vertical-align:baseline;color:rgba(85,146,206,1);">3. </span><span id="f5" style="font-size:12px;vertical-align:baseline;color:rgba(85,146,206,1);">솔리암페톨</span><span id="f4" style="font-size:12px;vertical-align:baseline;color:rgba(85,146,206,1);">: </span><span id="f5" style="font-size:12px;vertical-align:baseline;color:rgba(85,146,206,1);">판매허가가 임박했다</span></div>
<div class="txt" style="position:absolute; left:191px; top:455px;"><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">가장 진행이 빠른 품목으로는 수면장애 신약 솔리암페톨</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">(Solriamfetol, JZP-</span></div>
<div class="txt" style="position:absolute; left:191px; top:471px;"><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">110, SKL-N05)</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">이다</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. </span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">솔리암페톨은 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">SK</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">바이오팜이 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">2011</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">년 아일랜드 제약사</span></div>
<div class="txt" style="position:absolute; left:191px; top:487px;"><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">Jazz Pharmaceutical(</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">이하 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">Jazz)</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">에 기술 수출한 품목으로 올해 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">3</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">월 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">21</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">일</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">(</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">현지</span></div>
<div class="txt" style="position:absolute; left:191px; top:503px;"><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">시간</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">)</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">에 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">FDA</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">의 최종 판매허가 여부가 결정된다</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. </span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">판매가 승인될 경우 출시는 올</span></div>
<div class="txt" style="position:absolute; left:191px; top:519px;"><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">해 중순 경에 이루어질 전망이다</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. </span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">미국과 유럽시장은 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">Jazz</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">가</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">, </span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">아시아는 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">SK</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">바이오</span></div>
<div class="txt" style="position:absolute; left:191px; top:535px;"><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">팜이 직접 판매를 담당하게 되며 생산은 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">SK</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">바이오텍이 맡게 될 예정이다</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. SK</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">바</span></div>
<div class="txt" style="position:absolute; left:191px; top:551px;"><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">이오팜은 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">Jazz</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">로부터는 글로벌 매출에 대한 로열티를 수취하게 되며 아시아 시장</span></div>
<div class="txt" style="position:absolute; left:191px; top:567px;"><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">은 직접판매를 통해 매출을 인식하고 매출원가 중 일부는 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">SK</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">바이오텍의 매출로</span></div>
<div class="txt" style="position:absolute; left:191px; top:583px;"><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">계상되는 수익구조가 될 것으로 예상한다</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">.</span></div>
<div class="txt" style="position:absolute; left:191px; top:615px;"><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">솔리암페톨은 기면증</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">(Narcolepsy, </span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">밤에 잠을 충분히 잤어도 낮에 갑자기 졸음에</span></div>
<div class="txt" style="position:absolute; left:191px; top:631px;"><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">빠져드는 증세</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">)</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">이나 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">OSA(Obstructive Sleep Apnea, </span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">폐쇄수면무호흡증</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">)</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">로 인한</span></div>
<div class="txt" style="position:absolute; left:191px; top:647px;"><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">성인의 과도한 주간 졸림증</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">(Excessive Daytime Sleepiness)</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">을 개선해주는 수</span></div>
<div class="txt" style="position:absolute; left:191px; top:663px;"><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">면장애 치료제로 일종의 각성제</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">(wake-promoting agent)</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">다</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. 2012</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">년 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">8</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">월에는</span></div>
<div class="txt" style="position:absolute; left:191px; top:679px;"><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">FDA</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">로부터 희귀의약품으로 지정받았다</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. </span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">미국수면학회</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">(American Sleep</span></div>
<div class="txt" style="position:absolute; left:191px; top:695px;"><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">Association)</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">에 따르면 미국에는 적어도 한 달에 한 번 운전 중에 잠에 빠지는</span></div>
<div class="txt" style="position:absolute; left:191px; top:711px;"><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">기면증 환자 수는 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">250</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">만명에서 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">350</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">만명에 불과하나 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">OSA </span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">환자 수는 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">2,500</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">만명</span></div>
<div class="txt" style="position:absolute; left:191px; top:727px;"><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">달하는 것으로 나타났다</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">. </span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">반면 환자가 자신의 증상을 알아차리기 힘들며 생명에</span></div>
<div class="txt" style="position:absolute; left:191px; top:743px;"><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">큰 지장이 없다는 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">OSA</span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">의 특성상 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">OSA </span><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">환자들 중 약물을 처방 받는 비중은 </span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">10%</span></div>
<div class="txt" style="position:absolute; left:191px; top:759px;"><span id="f6" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">이하인 것으로 파악된다</span><span id="f3" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">.</span></div>
<div class="txt" style="position:absolute; left:526px; top:802px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(128,128,128,1);">5</span></div>
</body>
</html>
